Robert J. Kammer, Director at HARROW HEALTH, INC. (HROW), sold 10,000 shares at $6.91 ($69K) on 2019-03-01, disclosed to the SEC on 2019-03-04.
Open-market sale of $69k HROW by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HROW | SELL | 2019-09-11 | $37K | — | Filing → |
| HROW | SELL | 2019-08-14 | $45K | — | Filing → |
| HROW | SELL | 2019-07-16 | $51K | — | Filing → |